<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03066726</url>
  </required_header>
  <id_info>
    <org_study_id>RU10312017</org_study_id>
    <nct_id>NCT03066726</nct_id>
  </id_info>
  <brief_title>Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?</brief_title>
  <acronym>CPR</acronym>
  <official_title>Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virtua Medical Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint Peters University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Winthrop University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York Presbyterian Queens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ultrasound Doppler studies are used during pregnancy to help manage pregnancies complicated
      by fetal growth restriction. The cerebroplacental ratio may predict adverse outcomes in low
      risk pregnancies. In a prospective study, the investigators will examine whether fetuses with
      an abnormal CPR at or near term are at increased risk for being delivered by cesarean,
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter prospective study of low-risk nulliparous women who will be recruited
      if they are having an ultrasound at 36 weeks of estimated gestational age or greater. As part
      of the study, women will have umbilical and middle cerebral artery Doppler studies and the
      CPR will be calculated by dividing the middle cerebral artery PI by the umbilical artery PI.
      Providers caring for study subjects will be blinded to this result. Pregnancy outcomes in
      women with CPR values less than the 10th percentile for gestational age will be compared to
      those with CPR values above the 10th percentile.

      A secondary aim of the study is to analyze CPR as a continuous variable.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cesarean delivery</measure>
    <time_frame>From labor to delivery</time_frame>
    <description>Cesarean delivery rate for non reassuring fetal heart tracings</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total cesarean section rate</measure>
    <time_frame>From labor to delivery</time_frame>
    <description>Cesarean delivery rate for other indications other than non reassuring fetal heart tracings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cord blood gases</measure>
    <time_frame>At the time of delivery</time_frame>
    <description>If obtained by the provider, umbilical (arterial or venous) cord pH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cases of small for gestational age undetected prenatally</measure>
    <time_frame>At time of delivery</time_frame>
    <description>Neonates that were small for gestational age at time of delivery but were not detected prenatally</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birthweight/ birthweight percentile</measure>
    <time_frame>At time of delivery</time_frame>
    <description>Neonate birth weight and percentiles according to established weight charts will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of category 2 or 3 tracings</measure>
    <time_frame>During labor</time_frame>
    <description>As defined by the National Institutes of Health-National Institute of Child Health and Human Development Fetal Heart Tracings definitions and classifications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of CPR by estimated fetal weight</measure>
    <time_frame>Measured during ultrasound between 36 weeks gestational age and delivery of the pregnancy.</time_frame>
    <description>We will assess whether there is an association between the CPR and sonographic estimation of fetal weight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of operative vaginal delivery</measure>
    <time_frame>At time of delivery</time_frame>
    <description>Vaginal deliveries needing forceps or vacuum assistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Intensive Care Unit admission</measure>
    <time_frame>Up to 28 days from delivery of the pregnancy</time_frame>
    <description>Percentage of neonates admitted to the neonatal intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar scores at 1 and 5 minute</measure>
    <time_frame>Scores assigned at 1 and 5 minutes of life by clinical staff.</time_frame>
    <description>Standard assessment tool applied to all neonates in participating centers by clinical staff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite neonatal outcome</measure>
    <time_frame>Up to 28 days from delivery of the pregnancy.</time_frame>
    <description>The investigators will record a composite neonatal outcome including-respiratory distress, apnea, infection, hypoglycemia, hyperbilirubinemia, hypothermia, neurologic complication and neonatal death.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Cerebroplacental Ratio</condition>
  <arm_group>
    <arm_group_label>CPR less than the 10%le</arm_group_label>
    <description>Group of patients with fetuses with cerebroplacental ratio less than 10%le</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPR greater or equal than 10%le</arm_group_label>
    <description>Group of patients with fetuses with cerebroplacental ratio greater or equal than 10%le</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This is a multicenter prospective study of low-risk nulliparous women who will be recruited
        if they are having an ultrasound at 36 weeks EGA or greater.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparous pregnant women between the ages of 18 and 45 years with low risk
             pregnancies who present for obstetrical ultrasound at 36 weeks of gestation or later
             with a planned delivery at a Perinatal Research Consortium hospital.

        Exclusion Criteria:

          -  Multifetal pregnancy at the time of presentation

          -  Known fetal chromosomal anomaly

          -  Known fetal malformation

          -  Preeclampsia

          -  Fetal growth restriction

          -  Multiparity

          -  Prior cesarean section

          -  Placental abnormalities such as previa or accreta

          -  Pregestational diabetes

          -  Plan to deliver outside the Perinatal Research Consortium affiliated hospitals
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd Rosen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers, The State University of New Jersey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mayra Cruz Ithier, MD, MS</last_name>
    <phone>301 335-2262</phone>
    <email>mayra.cruzithier@rutgers.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rutgers, The State University of New Jersey</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shama Khan, MPH, MS</last_name>
      <phone>732-235-6630</phone>
      <email>khansp@rwjms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Todd Rosen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mayra A Cruz Ithier, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Peters University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Vitale, DNP, RNC-OB</last_name>
      <phone>732-339-7602</phone>
      <email>tvitale@saintpetersuh.com</email>
    </contact>
    <investigator>
      <last_name>Kristy Palomares, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virtua Medical Group</name>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <zip>08080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Obermeier, CCRP, CCRC</last_name>
      <phone>856-291-8875</phone>
      <email>eobermeier@virtua.org</email>
    </contact>
    <investigator>
      <last_name>David Vettori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian-Queens Hospital</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosalyn Chan, MD, MPH</last_name>
      <phone>718-670-1633</phone>
      <email>roc9166@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Jessica Scholl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kym Byrnes, RN</last_name>
      <email>kbyrnes@winthrop.org</email>
    </contact>
    <investigator>
      <last_name>Wendy L Kinzler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Torres, MD</last_name>
      <email>ct2179@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Chia-Ling Nhan Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Prior T, Mullins E, Bennett P, Kumar S. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol. 2013 Feb;208(2):124.e1-6. doi: 10.1016/j.ajog.2012.11.016. Epub 2012 Nov 15.</citation>
    <PMID>23159689</PMID>
  </reference>
  <reference>
    <citation>Figueras F, Savchev S, Triunfo S, Crovetto F, Gratacos E. An integrated model with classification criteria to predict small-for-gestational-age fetuses at risk of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2015 Mar;45(3):279-85. doi: 10.1002/uog.14714. Epub 2015 Jan 27.</citation>
    <PMID>25358519</PMID>
  </reference>
  <reference>
    <citation>DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol. 2015 Jul;213(1):5-15. doi: 10.1016/j.ajog.2015.05.024. Review.</citation>
    <PMID>26113227</PMID>
  </reference>
  <results_reference>
    <citation>Morales-Rosell√≥ J, Khalil A, Morlando M, Papageorghiou A, Bhide A, Thilaganathan B. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term. Ultrasound Obstet Gynecol. 2014 Mar;43(3):303-10. doi: 10.1002/uog.13319.</citation>
    <PMID>24488879</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2017</study_first_submitted>
  <study_first_submitted_qc>February 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2017</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Todd Rosen, MD</investigator_full_name>
    <investigator_title>Director, Maternal-Fetal Medicine</investigator_title>
  </responsible_party>
  <keyword>Biophysical profile</keyword>
  <keyword>Cesarean section</keyword>
  <keyword>Estimated fetal weight</keyword>
  <keyword>Middle cerebral artery</keyword>
  <keyword>Umbilical artery</keyword>
  <keyword>Fetal growth restriction</keyword>
  <keyword>Pulsatility index</keyword>
  <keyword>Estimated gestational age</keyword>
  <keyword>Doppler</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

